Home › Funds › Frazier Life Sciences Management, L.P. › SVRA
Frazier Life Sciences Management, L.P. position in SVRA
Savara Inc · Health Care
Frazier Life Sciences Management, L.P. reported holding 9,720,852 shares of SVRA (Savara Inc) in its Q2 2026 13F filing — a position valued at US$59.9M, representing 1.30% of its reported portfolio and ranking #16 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s SVRA position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in SVRA in Q3 2023 at 4,000,000 shares (US$15.1M). The position peaked in Q2 2026 at 9,720,852 shares, worth US$59.9M. Across 12 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 9,720,852 shares valued at US$59.9M. Notable position changes include a 104% increase in Q2 2024 (shares rose 5% over the following quarter), a 32% increase in Q1 2025 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.00M | $15.12M | New |
| Q4 2023 | 4.00M | $18.80M | Hold |
| Q1 2024 | 4.00M | $19.92M | Hold |
| Q2 2024 | 8.16M | $32.87M | Add |
| Q3 2024 | 8.16M | $34.59M | Hold |
| Q4 2024 | 8.66M | $26.59M | Add |
| Q1 2025 | 11.46M | $31.75M | Add |
| Q2 2025 | 11.46M | $26.13M | Hold |
| Q3 2025 | 11.46M | $40.92M | Hold |
| Q4 2025 | 9.86M | $59.47M | Reduce |
| Q1 2026 | 9.72M | $53.08M | Reduce |
| Q2 2026 | 9.72M | $59.88M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SVRA and 13F data
SVRA (Savara Inc) is a Health Care company. 44 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SVRA
- NEA Management Company, LLC 24.47M sh · $150.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 17.60M sh · $108.42M · Q2 2026
- Venrock Adviser, LLC 14.75M sh · $90.84M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 13.57M sh · $83.59M · Q2 2026
- TCG Crossover Management, LLC 12.36M sh · $76.15M · Q2 2026
- Nantahala Capital Management, LLC 6.98M sh · $42.98M · Q2 2026
- Spruce Street Capital LP 3.45M sh · $21.27M · Q2 2026
- Rosalind Advisors, Inc. 3.18M sh · $19.58M · Q2 2026
- Vestal Point Capital, LP 2.72M sh · $16.76M · Q2 2026
- Affinity Asset Advisors, LLC 2.51M sh · $15.47M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 1.84M sh · $11.35M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.36M sh · $8.35M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held SVRA?
Frazier Life Sciences Management, L.P. has disclosed SVRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Frazier Life Sciences Management, L.P.'s current position in SVRA?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 9.72M shares of SVRA (Savara Inc), valued at $59.88M, representing 1.30% of its reported portfolio and ranking #16.
Has Frazier Life Sciences Management, L.P. been buying or selling SVRA?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in SVRA. The position peaked in Q2 2026 at 9.72M shares.
Which other funds hold SVRA?
Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.